InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
T+90 hit rate
0%
T+90 mean return
-7.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Jean-Michel CARLE GRANDMOUGIN, Chief Executive Officer. Director active across 1 company, notably EUROBIO-SCIENTIFIC. In total, 5 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €573k. Activity tracked since 4 May 2021. The latest transaction was disclosed on 18 May 2022 (Apport). Regulator: AMF. All data is accessible without signup.
Declarations5 total
876,909 shares@ €25.2897.5% of flowActionHors plateforme de négociation2022DD843698
55,380 shares0ActionHors plateforme de négociation2022DD832636
4,385 shares@ €28.60020.6% of flowActionEuronext Growth Paris2022DD814041
1,402 shares@ €20.00540.1% of flowActionEuronext Growth Paris2021DD759103
20,500 shares@ €20.46451.8% of flowActionEuronext Growth Paris2021DD744964
5 of 5 declarations
About Jean-Michel CARLE GRANDMOUGIN
Jean-Michel Carle Grandmougin is the Chairman & CEO of Eurobio-Scientific. He leads the company with a vision focused on innovation and the development of biotechnology solutions.
